Literature DB >> 24933248

FKBP51 reciprocally regulates GRα and PPARγ activation via the Akt-p38 pathway.

Lance A Stechschulte1, Terry D Hinds, Simona S Ghanem, Weinian Shou, Sonia M Najjar, Edwin R Sanchez.   

Abstract

FK506-binding protein 51 (FKBP51) is a negative regulator of glucocorticoid receptor-α (GRα), although the mechanism is unknown. We show here that FKBP51 is also a chaperone to peroxisome proliferator-activated receptor-γ (PPARγ), which is essential for activity, and uncover the mechanism underlying this differential regulation. In COS-7 cells, FKBP51 overexpression reduced GRα activity at a glucocorticoid response element-luciferase reporter, while increasing PPARγ activity at a peroxisome proliferator response element reporter. Conversely, FKBP51-deficient (knockout) (51KO) mouse embryonic fibroblasts (MEFs) showed elevated GRα but reduced PPARγ activities compared with those in wild-type MEFs. Phosphorylation is known to exert a similar pattern of reciprocal modulation of GRα and PPARγ. Knockdown of FKBP51 in 3T3-L1 preadipocytes increased phosphorylation of PPARγ at serine 112, a phospho-residue that inhibits activity. In 51KO cells, elevated phosphorylation of GRα at serines 220 and 234, phospho-residues that promote activity, was observed. Because FKBP51 is an essential chaperone to the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase, Akt signaling was investigated. Elevated Akt activation and increased activation of p38 kinase, a downstream target of Akt that phosphorylates GRα and PPARγ, were seen in 51KO MEFs, causing activation and inhibition, respectively. Inactivation of p38 with PD169316 reversed the effects of FKBP51 deficiency on GRα and PPARγ activities and reduced PPARγ phosphorylation. Last, loss of FKBP51 caused a shift of PPARγ from cytoplasm to nucleus, as previously shown for GRα. A model is proposed in which FKBP51 loss reciprocally regulates GRα and PPARγ via 2 complementary mechanisms: activation of Akt-p38-mediated phosphorylation and redistribution of the receptors to the nucleus for direct targeting by p38.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24933248      PMCID: PMC4116593          DOI: 10.1210/me.2014-1023

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  56 in total

1.  Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids.

Authors:  Tina R Hubler; Jonathan G Scammell
Journal:  Cell Stress Chaperones       Date:  2004       Impact factor: 3.667

2.  Mechanisms regulating the nuclear translocation of p38 MAP kinase.

Authors:  Xiaowei Gong; Xiaoyan Ming; Peng Deng; Yong Jiang
Journal:  J Cell Biochem       Date:  2010-08-15       Impact factor: 4.429

3.  p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211.

Authors:  Aaron L Miller; M Scott Webb; Alicja J Copik; Yongxin Wang; Betty H Johnson; Raj Kumar; E Brad Thompson
Journal:  Mol Endocrinol       Date:  2005-04-07

Review 4.  Glucocorticoid receptor phosphorylation: overview, function and cell cycle-dependence.

Authors:  J E Bodwell; J C Webster; C M Jewell; J A Cidlowski; J M Hu; A Munck
Journal:  J Steroid Biochem Mol Biol       Date:  1998-04       Impact factor: 4.292

5.  ASK1-P38 pathway is important for anoikis induced by microtubule-targeting aryl chloroethylureas.

Authors:  Jessica Fortin; Alexandre Patenaude; Réna G Deschesnes; Marie-France Côté; Eric Petitclerc; René C-Gaudreault
Journal:  J Pharm Pharm Sci       Date:  2010       Impact factor: 2.327

6.  Essential role for Co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology.

Authors:  Weidong Yong; Zuocheng Yang; Sumudra Periyasamy; Hanying Chen; Selcul Yucel; Wei Li; Leanne Y Lin; Irene M Wolf; Martin J Cohn; Laurence S Baskin; Edwin R Sa Nchez; Weinian Shou
Journal:  J Biol Chem       Date:  2006-12-01       Impact factor: 5.157

7.  Susceptibility to diet-induced hepatic steatosis and glucocorticoid resistance in FK506-binding protein 52-deficient mice.

Authors:  Manya Warrier; Terry D Hinds; Kelly J Ledford; Harrison A Cash; Payal R Patel; Thomas A Bowman; Lance A Stechschulte; Weidong Yong; Weinian Shou; Sonia M Najjar; Edwin R Sanchez
Journal:  Endocrinology       Date:  2010-04-28       Impact factor: 4.736

8.  Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest.

Authors:  Z Zuo; G Urban; J G Scammell; N M Dean; T K McLean; I Aragon; R E Honkanen
Journal:  Biochemistry       Date:  1999-07-13       Impact factor: 3.162

9.  Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages.

Authors:  Myriam Aouadi; Kathiane Laurent; Matthieu Prot; Yannick Le Marchand-Brustel; Bernard Binétruy; Frédéric Bost
Journal:  Diabetes       Date:  2006-02       Impact factor: 9.461

10.  Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506.

Authors:  Todd H Davies; Yang-Min Ning; Edwin R Sánchez
Journal:  Biochemistry       Date:  2005-02-15       Impact factor: 3.162

View more
  22 in total

1.  Coupling of Conformational Transitions in the N-terminal Domain of the 51-kDa FK506-binding Protein (FKBP51) Near Its Site of Interaction with the Steroid Receptor Proteins.

Authors:  David M LeMaster; Sourajit M Mustafi; Matthew Brecher; Jing Zhang; Annie Héroux; Hongmin Li; Griselda Hernández
Journal:  J Biol Chem       Date:  2015-05-07       Impact factor: 5.157

2.  The stressed brain: regional and stress-related corticosterone and stress-regulated gene expression in the adult zebra finch (Taeniopygia guttata).

Authors:  Michelle A Rensel; Barney A Schlinger
Journal:  J Neuroendocrinol       Date:  2020-05-04       Impact factor: 3.627

3.  Hsp90-binding immunophilin FKBP51 forms complexes with hTERT enhancing telomerase activity.

Authors:  Mariana Lagadari; Nadia R Zgajnar; Luciana I Gallo; Mario D Galigniana
Journal:  Mol Oncol       Date:  2016-05-17       Impact factor: 6.603

4.  Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator-activated receptor α.

Authors:  Darren M Gordon; Kari L Neifer; Abdul-Rizaq Ali Hamoud; Charles F Hawk; Andrea L Nestor-Kalinoski; Scott A Miruzzi; Michael P Morran; Samuel O Adeosun; Jeffrey G Sarver; Paul W Erhardt; Robert E McCullumsmith; David E Stec; Terry D Hinds
Journal:  J Biol Chem       Date:  2020-05-13       Impact factor: 5.157

Review 5.  The glucocorticoid receptor: cause of or cure for obesity?

Authors:  Kezia John; Joseph S Marino; Edwin R Sanchez; Terry D Hinds
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-12-29       Impact factor: 4.310

6.  β-Arrestin-1 inhibits glucocorticoid receptor turnover and alters glucocorticoid signaling.

Authors:  Maria G Petrillo; Robert H Oakley; John A Cidlowski
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

Review 7.  Conformational Dynamics in FKBP Domains: Relevance to Molecular Signaling and Drug Design.

Authors:  David M LeMaster; Griselda Hernandez
Journal:  Curr Mol Pharmacol       Date:  2015       Impact factor: 3.339

8.  FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRα and PPARγ.

Authors:  Lance A Stechschulte; Terry D Hinds; Saja S Khuder; Weinian Shou; Sonia M Najjar; Edwin R Sanchez
Journal:  Mol Endocrinol       Date:  2014-06-16

9.  FKBP51 Null Mice Are Resistant to Diet-Induced Obesity and the PPARγ Agonist Rosiglitazone.

Authors:  Lance A Stechschulte; Bin Qiu; Manya Warrier; Terry D Hinds; Man Zhang; Hao Gu; Yuxue Xu; Saja S Khuder; Lucia Russo; Sonia M Najjar; Beata Lecka-Czernik; Weidong Yong; Edwin R Sanchez
Journal:  Endocrinology       Date:  2016-07-21       Impact factor: 4.736

Review 10.  Adipogenesis is under surveillance of Hsp90 and the high molecular weight Immunophilin FKBP51.

Authors:  Judith Toneatto; Nancy L Charó; Natalia M Galigniana; Graciela Piwien-Pilipuk
Journal:  Adipocyte       Date:  2015-05-13       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.